Abstract:Aminopeptidase N(APN/CD13) is an important zinc dependent metallo-exopeptidase,which is over expressed in tumor cells and plays a critical role in tumor invasion,metastasis and tumor angiogenesis.In order to find better aminopeptidase N inhibitors,One N-substituted-2,6-dioxopiperidin derivative(S)-2-amino-N-((S)-1-(2-(2-(dimethylamino)ethylamino)-2-oxoethyl)-2,6-dioxopiperidin-3-yl)-3-phenylpropanamide(8) was synthesized.Boc-L-glutamine(2) was synthesized from optical pure L-glutamine by protection with(Boc)2O and then cyclization in the presence of DCC and NHSu in THF.(S)-tert-butyl-2,6-dioxopiperidin-3-ylcarbamate(3),which was synthesized by alkylation of compound 2 with benzyl bromoacetate,was then treated with TFA to give compound 4.Then compound 4 was coupled with Boc-L-Phe to give compound 5,which was then catalytically hydrogenated using 10% Pd/C to afford compound 6.Coupling between compound 6 and N,N-dimethylpropan-1-amine in the presence of CDI gave compound 7.Compound 7 was finally treacted with HCl-EtOAc to give the target compound 8.The in vitro inhibitory activity of the target compound against APN was evaluated,and the IC50 value was 56.4 μmol · L-1(the IC50 value of the control Bestatin was 3.6 μmol · L-1).The result showed that the target compound had some activity while it need further modification to find better APN inhibitors.

Aminopeptidase N (EC 3.4.11.2) inhibitors (2006 - 2010): a patent review.

Aminopeptidase N (EC 3.4.11.2) Inhibitors (2006 – 2010): a Patent Review

Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors.

Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.

Recent advance in aminopeptidase N (APN/CD13) inhibitor research.

Novel Aminopeptidase N Inhibitors Derived from Antineoplaston AS2–5 (part I)

Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.

Novel Aminopeptidase N (APN/CD13) Inhibitors Derived from 3-Phenylalanyl-n'-substituted-2,6-piperidinedione.

Novel 3-Phenylpropane-1,2-diamine Derivates As Inhibitors of Aminopeptidase N (APN).

Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions

Establishment of a Screening Protocol for Identification of Aminopeptidase N Inhibitors

Design,synthesis and Bioactivity Evalution of N-substituted-2,6-dioxopiperidin Derivatives As Aminopeptidase N(APN/CD13) Inhibitors

Design, Synthesis and Biological Evaluation of New Pyrazoline-Based Hydroxamic Acid Derivatives as Aminopeptidase N (APN) Inhibitors.

Novel Leucine Ureido Derivatives As Inhibitors of Aminopeptidase N (APN).

Design, Synthesis and Biological Evaluation of Novel Amino Acid Ureido Derivatives As Aminopeptidase N/CD13 Inhibitors

Novel aminopeptidase N (APN/CD13) inhibitors derived from chloramphenicol amine.

Design, Synthesis And Activity Study Of Aminopeptidase N Targeted 3-Amino-2-Hydroxy-4-Phenyl-Butanoic Acid Derivatives

Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

Design,synthesis and activity study of aminopeptidase N targeted N-substituted-2,5-dioxopyrrolidin peptidomimetics

Activity Screening and Structure-Activity Relationship of the Hit Compounds Targeting Apn/Cd13

Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.